Nosocomial infections after severe trauma are associated with lower apolipoproteins B and AII

Journal of Trauma and Acute Care Surgery

Volumn 74, Issue 4, 2013, Pages 1067-1073

  Femling, Jon K ^a   West, Sonlee D ^a   Hauswald, Erik K ^a   Gresham, Hattie D ^b   Hall, Pamela R ^c  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

apolipoprotein; biomarker; inflammation; nosocomial infection; Trauma

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN B; INTERLEUKIN 6;

ACINETOBACTER INFECTION; ADULT; ARTICLE; BACTEROIDES INFECTION; BLOOD TRANSFUSION; BLOODSTREAM INFECTION; CANDIDIASIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI INFECTION; FEMALE; HOSPITAL INFECTION; HUMAN; INJURY SCALE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE INFECTION; LIPOPROTEIN BLOOD LEVEL; MALE; PNEUMONIA; POSTTRAUMATIC COMPLICATION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; STAPHYLOCOCCUS INFECTION; URINARY TRACT INFECTION;

ADULT; APOLIPOPROTEIN A-II; APOLIPOPROTEINS B; CROSS INFECTION; FEMALE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; NEW MEXICO; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRAUMA CENTERS; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84876176427     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182826be0     Document Type: Article

References (30)

1. Fraser DR, Dombrovskiy VY, Vogel TR. Infectious complications after vehicular trauma in the United States. Surg Infect (Larchmt). 2011; 12:291-296.
2. Baker SP, O'Neill B, Haddon W Jr, et al. The Injury Severity Score: a method for describing patients with multiple injuries and evaluating emergency care. J Trauma. 1974;14:187-196.
3. Stoner HB, Barton RN, Little RA, et al. Measuring the severity of injury. Br Med J. 1977;2:1247-1249.
4. Offner PJ, Moore EE, Biffl WL, et al. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg. 2002;137: 711-716; discussion 716-7.
5. Bochicchio GV, Napolitano L, Joshi M, et al. Outcome analysis of blood product transfusion in trauma patients: a prospective, risk-adjusted study. World J Surg. 2008;32:2185-2189.
6. Bogner V, Keil L, Kanz KG, et al. Very early posttraumatic serum alterations are significantly associated to initial massive RBC substitution, injury severity, multiple organ failure and adverse clinical outcome in multiple injured patients. Eur J Med Res. 2009;14:2842013291.
7. Hoover L, Bochicchio GV, Napolitano LM, et al. Systemic inflammatory response syndrome and nosocomial infection in trauma. J Trauma. 2006;61:310-316; discussion 316-7.
8. Hwang SY, Lee JH, Lee YH, et al. Comparison of the Sequential Organ Failure Assessment, Acute Physiology and Chronic Health Evaluation II scoring system, and Trauma and Injury Severity Score method for predicting the outcomes of intensive care unit trauma patients. Am J Emerg Med. 2011.
9. van Leeuwen HJ, Heezius EC, Dallinga GM, et al. Lipoprotein metabolism in patients with severe sepsis. Crit Care Med. 2003;31:1359-1366.
10. Lausevic Z, Lausevic M, Trbojevic-Stankovic J, et al. Predicting multiple organ failure in patients with severe trauma. Can J Surg. 2008;51:97-102.
11. West SD, Mold C. Monocyte deactivation correlates with Injury Severity Score, but not with heme oxygenase-1 levels in trauma patients. J Surg Res. 2011.
12. Polk HC Jr, George CD, Hershman MJ, et al. The capacity of serum to support neutrophil phagocytosis is a vital host defense mechanism in severely injured patients. Ann Surg. 1988;207:686-692.
13. Taylor JV, Gordon LE, Hall H, et al. Differences between bacterial species shown by simultaneous assessment of neutrophil phagocytosis and generation of reactive oxygen intermediates in trauma patients. Arch Surg. 1999;134:1222-1227; discussion 1227-8.
14. Hietbrink F, Koenderman L, Althuizen M, et al. Modulation of the innate immune response after trauma visualised by a change in functional PMN phenotype. Injury. 2009;40:851-855.
15. Midwinter MJ, Woolley T. Resuscitation and coagulation in the severely injured trauma patient. Philos Trans R Soc Lond B Biol Sci. 2011;366: 192-203.
16. Kimura F, Shimizu H, Yoshidome H, et al. Immunosuppression following surgical and traumatic injury. Surg Today. 2010;40:793-808.
17. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem. 1986;32:142-145.
18. Jacobson TA. Opening a new lipid "apo-thecary": incorporating apoli-poproteins as potential risk factors and treatment targets to reduce cardiovascular risk. Mayo Clin Proc. 2011;86:762-780.
19. Contois JH, Warnick GR, Sniderman AD. Reliability of low-density li-poprotein cholesterol, non-high-density lipoprotein cholesterol, and apo-lipoprotein B measurement. J Clin Lipidol. 2011;5:264-272.
20. Thaveeratitham P, Plengpanich W, Naen-Udorn W, et al. Effects of human apolipoprotein A-I on endotoxin-induced leukocyte adhesion on endo-thelial cells in vivo and on the growth of Escherichia coli in vitro. J En-dotoxin Res. 2007;13:58201364.
21. Biedzka-Sarek M, Metso J, Kateifides A, et al. Apolipoprotein A-I exerts bactericidal activity against Yersinia enterocolitica serotype O:3. J Biol Chem. 2011;286:38211-38219.
22. Estin ML, Stoltz DA, Zabner J. Paraoxonase 1, quorum sensing, and P. aeruginosa infection: a novel model. Adv Exp Med Biol. 2010;660: 183-193.
23. Furlong CE, Suzuki SM, Stevens RC, et al. Human PON1, a biomarker of risk of disease and exposure. Chem Biol Interact. 2010;187:355-361.
24. Stoltz DA, Ozer EA, Taft PJ, et al. Drosophila are protected from Pseu-domonas aeruginosa lethality by transgenic expression of paraoxonase-1. J Clin Invest. 2008;118:3123-3131.
25. Surewaard BG, Nijland R, Spaan AN, et al. Inactivation of staphylococcal phenol soluble modulins by serum lipoprotein particles. PLoS Pathog. 2012;8:e1002606.
26. Peterson MM, Mack JL, Hall PR, et al. Apolipoprotein B is an innate barrier against invasive Staphylococcus aureus infection. Cell Host Microbe. 2008;4:555-566.
27. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309-332.
28. Niven DJ, Fick GH, Kirkpatrick AW, et al. Cost and outcomes of noso-comial bloodstream infections complicating major traumatic injury. J Hosp Infect. 2010;76:296-299.
29. Bagdade J, Pedersen BK, Schwenke D, et al. Acute effects of interleukin-6 infusion on apo-B-containing lipoprotein subclasses in humans. Scand J Clin Lab Invest. 2011;71:449-455.
30. Tabah A, Koulenti D, Laupland K, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012.